Suppr超能文献

患有转甲状腺素蛋白淀粉样变性突变的症状前患者的整体纵向应变

Global longitudinal strain in pre-symptomatic patients with mutation for transthyretin amyloidosis.

作者信息

Canciello Grazia, Tozza Stefano, Todde Gaetano, Nolano Maria, Borrelli Felice, Palumbo Giovanni, Lombardi Raffaella, Cassano Emanuele, Acampa Wanda, Esposito Giovanni, Manganelli Fiore, Losi Maria Angela

机构信息

Department of Advanced Biomedical Sciences, University Federico II of Naples, Naples, Italy.

Department of Neuroscience and Reproductive and Odontostomatological Sciences, University Federico II of Naples, Via S Pansini 5, 80131, Naples, Italy.

出版信息

Orphanet J Rare Dis. 2024 Dec 5;19(1):458. doi: 10.1186/s13023-024-03473-7.

Abstract

BACKGROUND

Hereditary transthyretin (ATTRv) amyloidosis is rare, autosomal dominant disease with a fatal outcome if left untreated. Early stages detection is crucial for intervention. We aimed identifying early indexes of cardiac involvement and their eventual correlation with neurological indexes, in pre-symptomatic subjects with TTR gene mutation.

METHODS

Sixteen TTR-mutation carriers (mean age 51 ± 9 years, 6 males, 7 with Val30Met and 9 with Phe64Leu mutation) without left ventricular hypertrophy were studied. Predicted Age of Disease Onset (PADO) and time to PADO (Time-to PADO = PADO-age at evaluation) were computed. Subjects underwent: cardiological and echocardiographic assessment including global longitudinal strain (GLS); tactile and thermal quantitative sensory testing (QST); Perugini score by bone scintigraphy.

RESULTS

Time to PADO was 30 ± 15 years. Nine subjects showed abnormal GLS (> -20%), unrelated to age, LVMi, MWT, E/e', NT-proBNP or Time-to PADO. QST findings were abnormal in most subjects. At a worse cold pain threshold corresponded a worse GLS (r = 0.786, p < 0.001). Perugini score was positive in 1 subject.

CONCLUSIONS

GLS and QST findings support an early involvement of heart and small nerve fibers even many years before PADO. Interestingly, cardiac impairment seems to parallel that of small, nerve fibers, at least in the earliest stage of disease.

摘要

背景

遗传性转甲状腺素蛋白(ATTRv)淀粉样变性病较为罕见,是一种常染色体显性疾病,若不治疗会导致致命后果。早期检测对于干预至关重要。我们旨在确定TTR基因突变的无症状受试者心脏受累的早期指标及其与神经学指标的最终相关性。

方法

对16名无左心室肥厚的TTR基因突变携带者(平均年龄51±9岁,6名男性,7名携带Val30Met突变,9名携带Phe64Leu突变)进行了研究。计算了疾病预测发病年龄(PADO)和至PADO的时间(至PADO时间=PADO-评估时年龄)。受试者接受了以下检查:心脏和超声心动图评估,包括整体纵向应变(GLS);触觉和热定量感觉测试(QST);骨闪烁显像的佩鲁吉尼评分。

结果

至PADO时间为30±15年。9名受试者的GLS异常(> -20%),与年龄、左心室质量指数(LVMi)、肌肉重量(MWT)、E/A比值、N末端脑钠肽前体(NT-proBNP)或至PADO时间无关。大多数受试者的QST结果异常。冷痛阈值越差,GLS越差(r = 0.786,p < 0.001)。1名受试者的佩鲁吉尼评分为阳性。

结论

GLS和QST结果支持在PADO前许多年心脏和小神经纤维就已早期受累。有趣的是,至少在疾病的最早阶段,心脏损害似乎与小神经纤维的损害平行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8e2/11619093/ad7e492a4303/13023_2024_3473_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验